MSB 0.36% $1.39 mesoblast limited

2023 The Final Countdown, page-1169

  1. 12,359 Posts.
    lightbulb Created with Sketch. 1105
    Hi Wilba,
    I doubt Krause has joined for CLBP.
    They have done 2 phase 3 trials for CHF and I believe have
    a strong chance of LVAD approval.

    Aloha,
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.